Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
PolarityBio thanks the clinical trial sites and, most importantly, the participants, for making this milestone in DFU biologic therapy development possibleFinal trial results anticipated in the first...
-
SALT LAKE CITY, Oct. 29, 2025 (GLOBE NEWSWIRE) -- PolarityBio, a clinical-stage biotechnology company focused on addressing unmet needs in wound healing through innovation in autologous regenerative...
-
PolarityBio announced the launch of an Expanded Access Treatment Protocol (EAP) to provide continued access to SkinTE® for patients.
-
PolarityBio announced its participation in the Symposium on Advanced Wound Care (SAWC) Fall 2025.
-
PolarityBio today announced the completion of patient enrollment in COVER DFUS II, a Pivotal Phase III Multicenter Randomized Controlled Trial (RCT).